<![CDATA[Pharma — Maj 2023]]>Astellas Pharma To Acquire Iveric Bio In $5.9 Bln Deal https://www.proinvestor.com/investornyt/976671/astellas-pharma-to-acquire-iveric-bio-in-59-bln-deal

]]>https://dev.proinvestor.com/forum/topic/400874/pharma-maj-2023RSS for NodeSun, 07 Jun 2026 05:44:02 GMTMon, 01 May 2023 02:37:45 GMT60<![CDATA[Reply to Pharma — Maj 2023 on Wed, 31 May 2023 03:46:18 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8037819https://dev.proinvestor.com/forum/post/8037819Wed, 31 May 2023 03:46:18 GMT<![CDATA[Reply to Pharma — Maj 2023 on Thu, 25 May 2023 03:43:49 GMT]]>Sandoz : EMA Accepts MAA For Proposed Biosimilar Denosumab https://www.proinvestor.com/investornyt/991161/sandoz-ema-accepts-maa-for-proposed-biosimilar-denosumab

]]>https://dev.proinvestor.com/forum/post/8037814https://dev.proinvestor.com/forum/post/8037814Thu, 25 May 2023 03:43:49 GMT<![CDATA[Reply to Pharma — Maj 2023 on Tue, 23 May 2023 03:38:05 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8037815https://dev.proinvestor.com/forum/post/8037815Tue, 23 May 2023 03:38:05 GMT<![CDATA[Reply to Pharma — Maj 2023 on Mon, 22 May 2023 02:39:33 GMT]]>Sanofi:Dupixent Phase 3 COPD Results Presented At ATS & Published In New England Journal Of Medicine https://www.proinvestor.com/investornyt/989207/sanofidupixent-phase-3-copd-results-presented-at-ats-amp-published-in-new-england-journal-of-medicine

]]>https://dev.proinvestor.com/forum/post/8037816https://dev.proinvestor.com/forum/post/8037816Mon, 22 May 2023 02:39:33 GMT<![CDATA[Reply to Pharma — Maj 2023 on Fri, 19 May 2023 04:10:20 GMT]]>Lilly's peresolimab hits main goal in Phase II rheumatoid arthritis study https://www.proinvestor.com/boards/112684/

]]>https://dev.proinvestor.com/forum/post/8037810https://dev.proinvestor.com/forum/post/8037810Fri, 19 May 2023 04:10:20 GMT<![CDATA[Reply to Pharma — Maj 2023 on Fri, 19 May 2023 04:09:43 GMT]]>Months after joining, Teva CEO pulls curtain back on strategy to return to growth https://firstwordpharma.com/story/5741789

]]>https://dev.proinvestor.com/forum/post/8037813https://dev.proinvestor.com/forum/post/8037813Fri, 19 May 2023 04:09:43 GMT<![CDATA[Reply to Pharma — Maj 2023 on Fri, 19 May 2023 02:36:00 GMT]]>FDA Approves AbbVie's Rinvoq As Once-Daily Pill For Crohn's Disease In Adults https://www.proinvestor.com/investornyt/988250/fda-approves-abbvies-rinvoq-as-once-daily-pill-for-crohns-disease-in-adults

]]>https://dev.proinvestor.com/forum/post/8037811https://dev.proinvestor.com/forum/post/8037811Fri, 19 May 2023 02:36:00 GMT<![CDATA[Reply to Pharma — Maj 2023 on Tue, 16 May 2023 02:17:09 GMT]]>Biogen : Canada Accepts New Drug Submission For Lecanemab As Treatment For Early Alzheimer's Disease https://www.proinvestor.com/investornyt/986031/biogen-canada-accepts-new-drug-submission-for-lecanemab-as-treatment-for-early-alzheimers-disease

]]>https://dev.proinvestor.com/forum/post/8037808https://dev.proinvestor.com/forum/post/8037808Tue, 16 May 2023 02:17:09 GMT<![CDATA[Reply to Pharma — Maj 2023 on Mon, 15 May 2023 08:16:38 GMT]]>hvad synes folk om lundbeck?

]]>https://dev.proinvestor.com/forum/post/8037812https://dev.proinvestor.com/forum/post/8037812Mon, 15 May 2023 08:16:38 GMT<![CDATA[Reply to Pharma — Maj 2023 on Mon, 15 May 2023 04:22:48 GMT]]>Novozymes får løftet sit kursmål til 520 kr. fra 510 kr. af finanshuset Bernstein, der gentager den positive anbefaling "outperform".

]]>https://dev.proinvestor.com/forum/post/8037818https://dev.proinvestor.com/forum/post/8037818Mon, 15 May 2023 04:22:48 GMT<![CDATA[Reply to Pharma — Maj 2023 on Mon, 15 May 2023 04:02:35 GMT]]>Lundbeck: Bestyrelsesmedlem køber aktier for knap 2 mio. kr.
7:56
Jakob Riis, der er bestyrelsesmedlem i Lundbeck, har købt aktier i medicinalselskabet for knap 2 mio. kr.

Det oplyser Lundbeck i en insidermeddelelse mandag morgen.

Bestyrelsesmedlemmet har købt 54.138 aktier for samlet 1.998.233,58 kr., svarende til en stykpris på 36,91 kr.

Købet er dateret til 12. maj.

Fredag blev B-aktien i Lundbeck handlet til 36,66 kr. efter et fald på 1,4 pct.

.\˙ MarketWire

]]>https://dev.proinvestor.com/forum/post/8037806https://dev.proinvestor.com/forum/post/8037806Mon, 15 May 2023 04:02:35 GMT<![CDATA[Reply to Pharma — Maj 2023 on Fri, 12 May 2023 14:24:41 GMT]]>Det har været en rigtig god uge for de pharma- og biotekaktier der debatteres flittigt her på Proinvestor. Tak for indsatsen og god weekend til alle. 🙂

]]>https://dev.proinvestor.com/forum/post/8037817https://dev.proinvestor.com/forum/post/8037817Fri, 12 May 2023 14:24:41 GMT<![CDATA[Reply to Pharma — Maj 2023 on Fri, 12 May 2023 02:59:03 GMT]]>Lundbeck får hævet kursmål af Deutsche Bank efter regnskab https://www.proinvestor.com/investornyt/984356/lundbeck-far-haevet-kursmal-af-deutsche-bank-efter-regnskab

]]>https://dev.proinvestor.com/forum/post/8037803https://dev.proinvestor.com/forum/post/8037803Fri, 12 May 2023 02:59:03 GMT<![CDATA[Reply to Pharma — Maj 2023 on Thu, 11 May 2023 11:23:40 GMT]]>Kort video: ALK-Abelló ' Bavarian Nordic ' Genmab ' Lundbeck ' Zealand Pharma ' Hansa Biopharma

Der er fest på ProInvestor.com - for næsten alle de mest populære pharma- og biotekselskaber på sitet er steget i kurs. https://www.proinvestor.com/boards/112581

]]>https://dev.proinvestor.com/forum/post/8037805https://dev.proinvestor.com/forum/post/8037805Thu, 11 May 2023 11:23:40 GMT<![CDATA[Reply to Pharma — Maj 2023 on Thu, 11 May 2023 04:47:59 GMT]]>"Enorm fornøjelse" for Lundbecks direktør med vigtig godkendelse https://www.proinvestor.com/investornyt/983406/enorm-fornojelse-for-lundbecks-direktor-med-vigtig-godkendelse

]]>https://dev.proinvestor.com/forum/post/8037804https://dev.proinvestor.com/forum/post/8037804Thu, 11 May 2023 04:47:59 GMT<![CDATA[Reply to Pharma — Maj 2023 on Thu, 11 May 2023 04:40:02 GMT]]>Lundbeck (+1,4%, 35,74) har torsdag morgen fået grønt lys fra de amerikanske sundhedsmyndigheder til markedsføring af Brexpiprazol som behandling af agitation - eller vredesudbrud - hos Alzheimers-patienter.

]]>https://dev.proinvestor.com/forum/post/8037809https://dev.proinvestor.com/forum/post/8037809Thu, 11 May 2023 04:40:02 GMT<![CDATA[Reply to Pharma — Maj 2023 on Wed, 10 May 2023 10:47:53 GMT]]>Lundbeck/Sydbank: Styrer mod prognosetoppen med stærkt første kvartal https://www.proinvestor.com/investornyt/982638/lundbeck-sydbank-styrer-mod-prognosetoppen-med-staerkt-forste-kvartal

]]>https://dev.proinvestor.com/forum/post/8037802https://dev.proinvestor.com/forum/post/8037802Wed, 10 May 2023 10:47:53 GMT<![CDATA[Reply to Pharma — Maj 2023 on Wed, 10 May 2023 07:25:17 GMT]]>Lundbeck overrasker positivt i første kvartal - Vyepti fortsætter frem
https://www.proinvestor.com/investornyt/982499/lundbeck-overrasker-positivt-i-forste-kvartal-vyepti-fortsaetter-frem

]]>https://dev.proinvestor.com/forum/post/8037797https://dev.proinvestor.com/forum/post/8037797Wed, 10 May 2023 07:25:17 GMT<![CDATA[Reply to Pharma — Maj 2023 on Tue, 09 May 2023 06:23:00 GMT]]>ALK's topchef om afdæmpet tabletsalg: Vi har jo ikke trykket på en panikknap https://www.proinvestor.com/investornyt/981634/alks-topchef-om-afdaempet-tabletsalg-vi-har-jo-ikke-trykket-pa-en-panikknap

]]>https://dev.proinvestor.com/forum/post/8037800https://dev.proinvestor.com/forum/post/8037800Tue, 09 May 2023 06:23:00 GMT<![CDATA[Reply to Pharma — Maj 2023 on Tue, 09 May 2023 04:54:30 GMT]]>Alk: Kan kvartalsregnskabet formilde nervøse investorer
https://www.proinvestor.com/boards/112527

]]>https://dev.proinvestor.com/forum/post/8037801https://dev.proinvestor.com/forum/post/8037801Tue, 09 May 2023 04:54:30 GMT<![CDATA[Reply to Pharma — Maj 2023 on Tue, 09 May 2023 03:54:09 GMT]]>ALK bekræfter toplinjevækst - har uændret bundlinje https://www.proinvestor.com/investornyt/981572/alk-bekraefter-toplinjevaekst-har-uaendret-bundlinje

]]>https://dev.proinvestor.com/forum/post/8037807https://dev.proinvestor.com/forum/post/8037807Tue, 09 May 2023 03:54:09 GMT<![CDATA[Reply to Pharma — Maj 2023 on Tue, 09 May 2023 03:27:38 GMT]]>ALK-ABELLO - Regnskab for Q1 2023
https://www.proinvestor.com/boards/112521

]]>https://dev.proinvestor.com/forum/post/8037794https://dev.proinvestor.com/forum/post/8037794Tue, 09 May 2023 03:27:38 GMT<![CDATA[Reply to Pharma — Maj 2023 on Mon, 08 May 2023 08:39:43 GMT]]>Mioklubben i dag Du kan i dagens afsnit høre mere om blandt andre Bakkafrost, Mowi, Grieg seafood. Nordic Halibut, Anavex, Genmab, Brain+, INSW, Norden, Pfizer, Novo Nordisk, Siemens Energy, Mercedes Benz Group, Ambu, Mærsk og Biogen.

Podcast: https://www.euroinvestor.dk/podcast/millionaerklubben-der-er-penge-i-sundhed

]]>https://dev.proinvestor.com/forum/post/8037799https://dev.proinvestor.com/forum/post/8037799Mon, 08 May 2023 08:39:43 GMT<![CDATA[Reply to Pharma — Maj 2023 on Thu, 04 May 2023 11:35:53 GMT]]>Kort video - Novo Nordisk ' Anavex ' Eli Lilly ' Biogen ' Brain+ -

Helge Larsen kigger bl.a. på regnskab fra Novo Nordisk og på Anavex og udviklingen inden for medicin mod alzheimers og demens. https://www.proinvestor.com/boards/112459/

]]>https://dev.proinvestor.com/forum/post/8037798https://dev.proinvestor.com/forum/post/8037798Thu, 04 May 2023 11:35:53 GMT